Stereolithography suitable for 3D printing pills

Written by Alexandra Thompson

Researchers from the University College London’s School of Pharmacy (UK) have demonstrated the possibility of fabricating oral drug-loaded tablets capable of controlled release by using a commercial stereolithography 3D printer. 3D printing medications is a growing area of interest, owing to its potential to develop more effective formulations and personalized dosages. The last year has shown much progress in this area, such as the first 3D printed drug being approved by US FDA and subsequently reaching the market. Stereolithography (SLA) is a layer-by-layer 3D printing technology using a liquid resin material that hardens upon printing and photopolymerization. Owing to its...

To view this content, please register now for access

It's completely free